Home > Newsletters > Devices & Diagnostics Letter > EC Urges Stiffest Level of Controls, Clearer Labeling for Nanotech
Devices & Diagnostics Letter
Oct. 22, 2012 | Vol. 39 No. 42
EC Urges Stiffest Level of Controls, Clearer Labeling for Nanotech
The European Commission is urging that medical devices containing nanomaterials be reclassified as Class III devices and subject to the “most severe conformity assessment,” due to risk of particles being released into the human body.
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.